New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.The companies, namely Sun Pharma, Zydus Lifesciences, and Dr. Reddy’s Laboratories, launched their variants a day after Hyderabad-based Natco Pharma launched its generic semaglutide injection in India, priced at Rs 1,290 per month.Sun Pharma launched semaglutide…
Trending
- Bad Boy Karthik Review (2026): A Brother’s Fight That Packs Enough Heart to Win You Over
- Matka King Review: Vijay Varma’s Finest Hour in a Gripping Bombay Crime Drama
- Pallichattambi Movie Review: Tovino Thomas Leads a Powerful Period Drama with Mass Appeal
- Mr X Movie Review: Stylish Spy Action Thriller Delivers Big-Screen Entertainment with Arya in Command
- Thimmarajupalli TV Movie Review: A Heartwarming Nostalgia Trip That Captures the Soul of Rural Telugu Cinema
- Bhooth Bangla Review: Akshay Kumar & Priyadarshan Deliver a Wildly Fun Horror-Comedy That Hits All the Right Notes
- Papam Prathap Review: A Wholesome Telugu Village Romance with Heart and Humor
- Toaster Netflix Review: Rajkummar Rao and Sanya Malhotra’s Dark Comedy Is the Most Fun You’ll Have Streaming This Week